Načítá se...
The EP3 receptor/G(z) signaling axis as a therapeutic target for diabetes and cardiovascular disease
Cardiovascular disease is a common co-morbidity found with obesity-linked type 2 diabetes. Current pharmaceuticals for these two diseases treat each of them separately. Yet, diabetes and cardiovascular disease share molecular signaling pathways that are increasingly being understood to contribute to...
Uloženo v:
| Vydáno v: | AAPS J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7934137/ https://ncbi.nlm.nih.gov/pubmed/28584908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-017-0097-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|